Food and Drug Administration (FDA) to approve cannabidiol (CBD) for use in dietary supplements.
House Resolution 841, also called the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021, was introduced by Democratic Oregon Rep. Kurt Schrader and Republican Virginia Rep Morgan Griffith, with five Republican and 12 Democratic co-sponsors. The bill would simply make hemp subject to all the regulations as any other dietary supplement – subject to new dietary ingredient (NDI) filings, Good Manufacturing Practices (GMP) and labeling and marketing provisions.
Under the bill, hemp’s definition as a cannabis plant with less than 0.3 percent tetrahydrocannabinol (THC) – the psychoactive constituent of cannabis – would remain unchanged. The focus on THC also means that other cannabinoids and terpenes within hemp can also be approved for use in dietary supplements.
Glutathione marketer agrees to drop treatment claims following NAD ruling The manufacturer of a glutathione supplement has agreed to cease certain health and performance claims associated with the product after a ruling by the National Advertising Division.
According to an NAD press release from BBB National Programs, Nanoceutical Solutions Inc. agreed to comply with the findings on its Nano Glutathione dietary supplement. The claims being made on the product were challenged by the Council for Responsible Nutrition.
Injection statement implied disease treatment linkage, NAD rules
The NAD press release said the company, which is based in San Antonio, TX, failed to provide sufficient evidence to support the claims made on the product.
Whatâs in Your Prenatal Vitamin?
Doctors recommend them before, during and even after a pregnancy. But regulation is spotty and finding the right pill can be hard.
Credit.Eleni Kalorkoti
Published Feb. 3, 2021Updated Feb. 4, 2021
When I told my doctor that I was thinking of getting pregnant a few years ago, she advised me to start taking a prenatal vitamin right away. So I stopped by the grocery store on my way home and made for the supplement aisle. As I studied the array of options before me, I quickly grew overwhelmed.
I noticed that different brands contained slightly different concoctions of ingredients, with wildly different amounts in each. Each multivitamin extolled its benefits, but also bore the familiar disclaimer that its claims had ânot been evaluated by the Food and Drug Administration,â which I found unsettling. Who, I wondered, was looking out for pregnant people?
Press release content from PR Newswire. The AP news staff was not involved in its creation.
NAD Recommends Nanoceutical Solutions Discontinue Certain Claims for Nano Glutathione Liquid Dietary Supplement and Modify Instagram Ad
February 2, 2021 GMT
National Advertising Division (NAD) (PRNewsfoto/National Advertising Division,B)
NEW YORK, Feb. 2, 2021 /PRNewswire/ The National Advertising Division (NAD) of BBB National Programs recommended that Nanoceutical Solutions, Inc. discontinue efficacy and establishment claims for its Nano Glutathione liquid dietary supplement due to a failure to provide sufficient evidence for the claims. The claims at issue were challenged by the Council for Responsible Nutrition (CRN).
NAD also recommended that Nanoceutical Solutions modify a “Conditions Associated with LOW Glutathione” Instagram advertisement to avoid conveying the misleading message that supplementation with Nano Glutathione can prevent or reduce the risk of the listed health c
An FDA document related to CBD that had been pending for several months before the White House has been withdrawn, consistent with a freeze on regulations and guidance documents issued by the administration of President Joe Biden.
While stakeholders had not seen the actual document “Cannabidiol Enforcement Policy; Draft Guidance for Industry” pending before the White House’s Office of Management and Budget (OMB) since July, many were hopeful that publication of the guidance would help provide some measure of certainty to an industry operating for years in a state of regulatory limbo at the national level.
Withdrawal of the policy highlights “two years have passed since the 2018 Farm Bill made CBD legal, and FDA has made no meaningful progress on a clear regulatory path for CBD consumer products,” said Duffy MacKay, senior vice president of scientific and regulatory affairs with San Diego-based CV Sciences Inc., a marketer of hemp-based CBD products, in an email. “In my